Clinical Trial: Open-angle Glaucoma Subjects on One Topical Hypotensive Medication Randomized to Treatment With One or Two Trabecular Micro-bypass Stents in Conjunction With Cataract Surgery
Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional
Official Title: A Prospective Evaluation of Open-angle Glaucoma Subjects on One Topical Hypotensive Medication Randomized to Treatment With One or Two Trabecular Micro-bypass Stents in Co
Brief Summary: Evaluation of intraocular pressure (IOP) lowering effect of one iStent versus two iStents in conjunction with cataract surgery in subjects with primary open-angle glaucoma, washed out of one anti-glaucoma medication prior to stent implantation.
Detailed Summary:
Sponsor: Glaukos Corporation
Current Primary Outcome: Mean diurnal IOP reduction of ≥ 20% vs. baseline mean diurnal IOP [ Time Frame: 12 Months ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Glaukos Corporation
Dates:
Date Received: September 28, 2011
Date Started: September 2011
Date Completion: April 2017
Last Updated: May 18, 2015
Last Verified: May 2015